Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Pharma 5.0
Company News
Events
Directory
Search
Close search
Home
Company
Rhenovia Pharma SAS
Rhenovia Pharma SAS
Activities:
Research & Development
Pharmaceutical
X
LinkedIn
Trending Articles
Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222
Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
Graphs and graph data science in drug discovery
Life sciences data expert Dr Alexander Jarasch discusses what work being done at the Institut de Recherches Servier can teach us about using modern data technologies for early...
The (r)evolution of biocatalysis in API synthesis
Explore Farmhispania Group’s enzyme toolbox to develop cost-effective, green-by-design synthetic routes for the cGMP production of your small-molecule NCEs
From batch to continuous chemistry to continuous processing
The main challenge in many flow reactors lies in achieving a smooth and continuous flow within microchannels. Dec Group focuses on effectively transporting solid materials and...
PCI Pharma Services commences installation of sterile fill-finish and lyophilisation line
The Bedford, NH site will advance PCI's manufacturing capabilities with twin lyophilisers and a large-scale isolator filling line, making this the third sterile fill-finish...
Upcoming event
ASGCT Annual Meeting 2024
7-11 May, 2024 | Meeting | Portland, OR
See all
Related Content
Drug Delivery
SMARTT e-Patch wins Worldwide Innovation Challenge award
In the personalised medicine category
Drug Delivery
Rhenovia files patent applications for RHEpatch
Intelligent transdermal patch combines multiple therapies for controlled drug delivery
Research & Development
Rhenovia to accelerate search for new treatments for rare diseases
Firm will initially build a new biosimulation platform
Research & Development
Rhenovia Pharma opens first US office
Aims to widen use of its biosimulation technology
Research & Development
Rhenovia signs partnership with AFM
To support its simulation technology for diseases of the nervous system
Research & Development
Rhenovia to lead US$3.75m biosimulation project
Extends CNS biosimulation platform to study of epilepsy
Subscribe now